Relieve Parkinson constipation through acupuncture
- Trial ID
- NCT06390761
- Official Title
- Acupuncture for the Treatment of Parkinson's Disease Related Constipation
- Goal
- Relieve Parkinson constipation through acupuncture
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Xi'an No.3 Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Disease, Constipation, Non-motor Symptom, Randomized Controlled Trial
- Interventions
- Acupuncture
Plain-Language Summary
The trial aims to see whether acupuncture can ease the constipation that many people with Parkinson's experience, by increasing bowel movement frequency and improving stool consistency. Needles are placed at specific points to stimulate nerves and influence the autonomic and enteric nervous systems, which may speed intestinal transit and alter pain and motility signaling; acupuncture does not directly affect levodopa and can be used with usual Parkinson's meds, though the study asks participants to stop other drugs that affect gut function for two weeks before starting. They're looking for people aged 35 to 80 with a confirmed Parkinson's diagnosis and functional constipation, at Hoehn-Yahr stage 1 to 3, without major GI disease, recent abdominal surgery, skin problems that prevent needling, pregnancy, or serious life-threatening illnesses. The study plans to enroll about 60 people and asks participants to keep a bowel diary and complete symptom scales.
Locations
- Xi 'an No.3 Hospital, Xi'an, Shaanxi, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Acupuncture. The trial aims to see whether acupuncture can ease the constipation that many people with Parkinson's experience, by increasing bowel movement frequency and improving stool consistency. Needles are placed at specific points to stimulate nerves and influence the autonomic and enteric nervous systems, which may speed intestinal transit and alter pain and motility signaling; acupuncture does not directly affect levodopa and can be used with usual Parkinson's meds, though the study asks participants to stop other drugs that affect gut function for two weeks before starting. They're looking for people aged 35 to 80 with a confirmed Parkinson's diagnosis and functional constipation, at Hoehn-Yahr stage 1 to 3, without major GI disease, recent abdominal surgery, skin problems that prevent needling, pregnancy, or serious life-threatening illnesses. The study plans to enroll about 60 people and asks participants to keep a bowel diary and complete symptom scales.
- Who can participate?
- Participants must be between 35 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.